Graviti Pharmaceuticals Private Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Survey No. 621/E & 621/EE, Isnapur Village, Patancheru Mandal, Sangareddy, Telangana 502307, India (IND)
- Operations here
- analysismanufacture
- FDA identifiers
- FEI 3012932394 · DUNS 650884781
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2023-02-03
Drugs this plant is listed as making
28 distinct drugs across 71 products name this site in their FDA label.
- Amitriptyline HydrochlorideRising Pharma Holdings, Inc.
- atorvastatin calcium, film coatedRising Pharma Holdings, Inc.
- bupropion hydrochlorideRising Pharma Holdings, Inc.
- Buspirone HydrochlorideRising Pharma Holdings, Inc.
- ChlorzoxazoneRising Pharma Holdings, Inc.
- Cyclobenzaprine HydrochlorideRising Pharma Holdings, Inc.
- escitalopramRising Pharma Holdings, Inc.
- esomeprazole magnesiumBiocon Pharma Inc.,
- FamotidineRising Pharma Holdings, Inc.
- FenofibrateLeading Pharma, LLC
- Fenofibric AcidLaurus Labs Limited
- Furosemidein shortageRising Pharma Holdings, Inc.
- gabapentinRising Pharma Holdings, Inc.
- hydroxyzine hydrochlorideRising Pharma Holdings, Inc.
- LevocarnitineRising Pharma Holdings, Inc.
- Lorazepamin shortageRising Pharma Holdings, Inc.
- Montelukast SodiumRising Pharma Holdings, Inc.
- Pantoprazole SodiumRising Pharma Holdings, Inc.
- tizanidineRising Pharma Holdings, Inc.
- Tramadol HydrochlorideRising Pharma Holdings, Inc.
- trazodone hydrochlorideRising Pharma Holdings, Inc.
- valacyclovir hydrochlorideJubilant Cadista Pharmaceuticals Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.